Siemens hears sweet music with €2.15bn deal for Audiology; sees Dx profit jump for Q4
This article was originally published in Clinica
Executive Summary
Money speaks volumes and when Siemens was offered a tidy sum for its successful hearing aids business, it could not turn a deaf ear. Previously-announced plans to spin out Siemens Audiology Solutions as a standalone publicly-listed company have been ditched and instead, the German group has signed a deal to sell the division to investment company EQT and Germany’s Strüngmann family of entrepreneurs as co-investor for €2.15bn ($2.67bn), plus future earn-outs.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.